• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伤口中血栓的黏附有助于止血,凝血因子 XIII 可增强其作用。

The adhesion of clots in wounds contributes to hemostasis and can be enhanced by coagulation factor XIII.

机构信息

Michael Smith Laboratories, University of British Columbia, 2185 East Mall, Vancouver, BC, V6T 1Z4, Canada.

Department of Emergency Medicine, University of Washington, Seattle, USA.

出版信息

Sci Rep. 2020 Nov 18;10(1):20116. doi: 10.1038/s41598-020-76782-z.

DOI:10.1038/s41598-020-76782-z
PMID:33208779
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7675984/
Abstract

The adhesion of blood clots to wounds is necessary to seal injured vasculature and achieve hemostasis. However, it has not been specifically tested if adhesive failure of clots is a major contributor to rebleeding and what mechanisms prevent clot delamination. Here, we quantified the contribution of adhesive and cohesive failure to rebleeding in a rat model of femoral artery injury, and identified mechanisms that contribute to the adhesive strength of bulk clots in a lap-shear test in vitro. In the rat bleeding model, the frequency of clot failures correlated positively with blood loss (R = 0.81, p = 0.014) and negatively with survival time (R =  - 0.89, p = 0.0030), with adhesive failures accounting for 51 ± 14% of rebleeds. In vitro, adhesion depended on fibrinogen and coagulation factor XIII (FXIII), and supraphysiological FXIII improved adhesive strength. Furthermore, when exogenous FXIII was topically applied into the wound pocket of rats, eleven adhesive failures occurred between eight rats, compared to seventeen adhesive failures between eight untreated rats, whereas the number of cohesive failures remained the same at sixteen in both groups. In conclusion, rebleeding from both adhesive and cohesive failure of clots decreases survival from hemorrhage in vivo. Both endogenous and exogenous FXIII improves the adhesive strength of clots.

摘要

血液凝块黏附于伤口对于封闭受损的脉管并实现止血是必要的。然而,尚未专门测试过凝块的黏附失败是否是再出血的主要原因,以及有哪些机制可以防止凝块分层。在这里,我们在大鼠股动脉损伤模型中定量评估了黏附失败和凝聚失败对再出血的贡献,并确定了体外层剪测试中 bulk clots 黏附强度的相关机制。在大鼠出血模型中,凝块失败的频率与失血量呈正相关(R=0.81,p=0.014),与存活时间呈负相关(R=−0.89,p=0.0030),黏附失败占再出血的 51±14%。在体外,黏附取决于纤维蛋白原和凝血因子 XIII(FXIII),且 FXIII 水平高于生理值时可以提高黏附强度。此外,当外源性 FXIII 局部应用于大鼠伤口口袋时,在 8 只大鼠中有 11 个黏附失败,而在 8 只未处理的大鼠中有 17 个黏附失败,而两组的凝聚失败数量均为 16。总之,体内凝块的黏附和凝聚失败都会导致出血时的存活率降低。内源性和外源性 FXIII 均可以提高凝块的黏附强度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c03/7675984/d407637bdca3/41598_2020_76782_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c03/7675984/0ea74bc20a51/41598_2020_76782_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c03/7675984/bbb9750ec481/41598_2020_76782_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c03/7675984/0be7825acd91/41598_2020_76782_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c03/7675984/d407637bdca3/41598_2020_76782_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c03/7675984/0ea74bc20a51/41598_2020_76782_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c03/7675984/bbb9750ec481/41598_2020_76782_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c03/7675984/0be7825acd91/41598_2020_76782_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c03/7675984/d407637bdca3/41598_2020_76782_Fig4_HTML.jpg

相似文献

1
The adhesion of clots in wounds contributes to hemostasis and can be enhanced by coagulation factor XIII.伤口中血栓的黏附有助于止血,凝血因子 XIII 可增强其作用。
Sci Rep. 2020 Nov 18;10(1):20116. doi: 10.1038/s41598-020-76782-z.
2
High-dose Factor XIII administration induces effective hemostasis for trauma-associated coagulopathy (TAC) both in vitro and in rat hemorrhagic shock in vivo models.大剂量因子 XIII 给药可有效止血创伤相关凝血病(TAC),无论是在体外还是在大鼠失血性休克体内模型中。
J Trauma Acute Care Surg. 2018 Sep;85(3):588-597. doi: 10.1097/TA.0000000000001998.
3
Factor XIII in plasma, but not in platelets, mediates red blood cell retention in clots and venous thrombus size in mice.血浆中的因子 XIII,而不是血小板,介导了红细胞在血栓中的滞留和静脉血栓的大小。
Blood Adv. 2018 Jan 3;2(1):25-35. doi: 10.1182/bloodadvances.2017011890. eCollection 2018 Jan 9.
4
The importance of factor XIII as a component of fibrin sealants.凝血因子 XIII 作为纤维蛋白密封剂成分的重要性。
J Surg Res. 2002 Oct;107(2):186-95. doi: 10.1006/jsre.2002.6495.
5
Relative effects of plasma, fibrinogen concentrate, and factor XIII on ROTEM coagulation profiles in an in vitro model of massive transfusion in trauma.在创伤大量输血体外模型中,血浆、纤维蛋白原浓缩物和凝血因子 XIII 对旋转血栓弹力图凝血曲线的相对影响。
Scand J Clin Lab Invest. 2017 Oct;77(6):397-405. doi: 10.1080/00365513.2017.1334128. Epub 2017 Jun 20.
6
Thromboelastograph assay for measuring the mechanical strength of fibrin sealant clots.用于测量纤维蛋白密封剂凝块机械强度的血栓弹力图测定法。
Clin Appl Thromb Hemost. 2000 Oct;6(4):226-33. doi: 10.1177/107602960000600408.
7
Clotting factor XIII and desmopressin improve hemostasis in uncontrolled bleeding.凝血因子 XIII 和去氨加压素可改善失控性出血中的止血情况。
Acta Cir Bras. 2015 Mar;30(3):170-7. doi: 10.1590/S0102-865020150030000002.
8
Complete hemostasis achieved by factor XIII concentrate administration in a patient with bleeding after teeth extraction as a complication of aplastic anemia and chronic disseminated intravascular coagulation.因再生障碍性贫血和慢性弥散性血管内凝血并发拔牙后出血,给予凝血因子 XIII 浓缩物治疗以实现完全止血。
Blood Coagul Fibrinolysis. 2020 Jun;31(4):274-278. doi: 10.1097/MBC.0000000000000902.
9
The effective control of a bleeding injury using a medical adhesive containing batroxobin.使用含有巴曲酶的医用粘合剂对出血性损伤进行有效控制。
Biomed Mater. 2014 Apr;9(2):025002. doi: 10.1088/1748-6041/9/2/025002. Epub 2014 Jan 31.
10
Fibrinogen depletion after plasma-dilution: impairment of proteolytic resistance and reversal via clotting factor concentrates.血浆稀释后纤维蛋白原耗竭:抗蛋白水解能力受损及通过凝血因子浓缩物逆转。
Thromb Haemost. 2014 Mar 3;111(3):417-28. doi: 10.1160/TH13-06-0497. Epub 2013 Nov 7.

引用本文的文献

1
Covalently reactive microparticles imbibe blood to form fortified clots for rapid hemostasis and prevention of rebleeding.具有共价反应性的微粒吸收血液以形成强化凝块,实现快速止血并防止再次出血。
Nat Commun. 2025 Apr 18;16(1):3705. doi: 10.1038/s41467-025-58204-8.
2
Reactive oxygen species: Orchestrating the delicate dance of platelet life and death.活性氧:编排血小板生死的微妙舞蹈。
Redox Biol. 2025 Mar;80:103489. doi: 10.1016/j.redox.2025.103489. Epub 2025 Jan 3.
3
Acquired Low Factor XIII Activity Is Associated with an Increased Need for Blood Transfusions in Patients with Gastrointestinal Bleedings.

本文引用的文献

1
Sustained depletion of FXIII-A by inducing acquired FXIII-B deficiency.通过诱导获得性 FXIII-B 缺乏来持续耗尽 FXIII-A。
Blood. 2020 Dec 17;136(25):2946-2954. doi: 10.1182/blood.2020004976.
2
Sensitivity of Viscoelastic Tests to Platelet Function.粘弹性试验对血小板功能的敏感性
J Clin Med. 2020 Jan 10;9(1):189. doi: 10.3390/jcm9010189.
3
Thromboelastography and Thromboelastometry in Assessment of Fibrinogen Deficiency and Prediction for Transfusion Requirement: A Descriptive Review.血栓弹力描记术和血栓弹力测量术在评估纤维蛋白原缺乏症和预测输血需求中的应用:描述性综述。
获得性低十三因子活性与胃肠道出血患者需要输血增加相关。
Dig Dis Sci. 2024 Oct;69(10):3894-3900. doi: 10.1007/s10620-024-08651-y. Epub 2024 Sep 19.
4
Liquid-infused microstructured bioadhesives halt non-compressible hemorrhage.液体浸润的微结构化生物黏合剂可止住不可压缩性出血。
Nat Commun. 2022 Aug 26;13(1):5035. doi: 10.1038/s41467-022-32803-1.
5
The impact of acquired coagulation factor XIII deficiency in traumatic bleeding and wound healing.获得性凝血因子 XIII 缺乏对创伤性出血和伤口愈合的影响。
Crit Care. 2022 Mar 24;26(1):69. doi: 10.1186/s13054-022-03940-2.
Biomed Res Int. 2018 Nov 25;2018:7020539. doi: 10.1155/2018/7020539. eCollection 2018.
4
Systemic hyperfibrinolysis after trauma: a pilot study of targeted proteomic analysis of superposed mechanisms in patient plasma.创伤后全身高纤溶状态:患者血浆中重叠机制的靶向蛋白质组学分析的初步研究。
J Trauma Acute Care Surg. 2018 Jun;84(6):929-938. doi: 10.1097/TA.0000000000001878.
5
Development and implementation of tPA clot lysis activity assay using ACL TOP™ hemeostasis testing system in QC laboratories.在质量控制实验室中使用ACL TOP™ 止血检测系统开发并实施组织型纤溶酶原激活剂(tPA)凝块溶解活性测定法。
Biotechnol Rep (Amst). 2017 Oct 27;16:58-64. doi: 10.1016/j.btre.2017.10.002. eCollection 2017 Dec.
6
A microfluidic model of hemostasis sensitive to platelet function and coagulation.一种对血小板功能和凝血敏感的止血微流控模型。
Cell Mol Bioeng. 2017 Feb;10(1):3-15. doi: 10.1007/s12195-016-0469-0. Epub 2016 Oct 24.
7
Role of red blood cells in haemostasis and thrombosis.红细胞在止血和血栓形成中的作用。
ISBT Sci Ser. 2017 Feb;12(1):176-183. doi: 10.1111/voxs.12331. Epub 2016 Dec 14.
8
Fibrin Formation, Structure and Properties.纤维蛋白的形成、结构与特性
Subcell Biochem. 2017;82:405-456. doi: 10.1007/978-3-319-49674-0_13.
9
PolySTAT-modified chitosan gauzes for improved hemostasis in external hemorrhage.用于改善外出血止血效果的聚STAT修饰壳聚糖纱布
Acta Biomater. 2016 Feb;31:178-185. doi: 10.1016/j.actbio.2015.11.017. Epub 2015 Nov 28.
10
Functional capacity of reconstituted blood in 1:1:1 versus 3:1:1 ratios: a thrombelastometry study.1:1:1与3:1:1比例的重组血液功能能力:血栓弹力图研究
Scand J Trauma Resusc Emerg Med. 2015 Jan 9;23:2. doi: 10.1186/s13049-014-0080-0.